Analyzing Female Health (VERU) & OMNOVA Solutions (OMN)

Female Health (NASDAQ: VERU) and OMNOVA Solutions (NYSE:OMN) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, earnings, profitability and institutional ownership.

Insider and Institutional Ownership

How to Become a New Pot Stock Millionaire

4.2% of Female Health shares are owned by institutional investors. Comparatively, 89.4% of OMNOVA Solutions shares are owned by institutional investors. 37.0% of Female Health shares are owned by company insiders. Comparatively, 4.6% of OMNOVA Solutions shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Volatility & Risk

Female Health has a beta of 0.68, suggesting that its stock price is 32% less volatile than the S&P 500. Comparatively, OMNOVA Solutions has a beta of 2.07, suggesting that its stock price is 107% more volatile than the S&P 500.

Earnings & Valuation

This table compares Female Health and OMNOVA Solutions’ revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Female Health $13.66 million 7.13 -$6.61 million ($0.25) -7.28
OMNOVA Solutions $783.10 million 0.63 -$87.80 million $0.56 19.55

Female Health has higher earnings, but lower revenue than OMNOVA Solutions. Female Health is trading at a lower price-to-earnings ratio than OMNOVA Solutions, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Female Health and OMNOVA Solutions’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Female Health -73.11% -17.63% -12.73%
OMNOVA Solutions -10.67% 32.70% 4.15%

Analyst Ratings

This is a summary of recent ratings and recommmendations for Female Health and OMNOVA Solutions, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Female Health 0 0 2 0 3.00
OMNOVA Solutions 0 1 2 0 2.67

Female Health presently has a consensus target price of $5.00, suggesting a potential upside of 174.73%. OMNOVA Solutions has a consensus target price of $12.00, suggesting a potential upside of 9.59%. Given Female Health’s stronger consensus rating and higher probable upside, research analysts clearly believe Female Health is more favorable than OMNOVA Solutions.

Summary

OMNOVA Solutions beats Female Health on 7 of the 12 factors compared between the two stocks.

About Female Health

Veru Inc. operates as a urology and oncology biopharmaceutical company. The company operates through two segments, Commercial; and Research and Development. It offers FC2 Female Condom for unintended pregnancy and sexually transmitted infections, including HIV/AIDS and the Zika virus; and PREBOOST benzocaine medicated individual wipes for the prevention of premature ejaculation. The company's urology drug candidates include Tamsulosin delayed release sachet and Tamsulosin XR capsules that are under bioequivalence study for the treatment of benign prostatic hyperplasia; and Solifenacin delayed release granules, which are under bioequivalence study for the treatment of overactive bladder. Its urology drug candidates also comprise Tadalafil-Finasteride combination capsules that are under bioequivalence study for the treatment of men with lower urinary tract symptoms and enlarged prostate; VERU-944, which is in Phase II clinical trial for the treatment of hot flashes in men on prostate cancer hormonal therapies; and VERU-722 that is in Phase II clinical trial for the treatment of male infertility caused by testicular dysfunction. The company's oncology drug candidate is VERU-111, a novel oral alpha and beta tubulin inhibitor, which is under preclinical study for the treatment of metastatic prostate, breast, endometrial, ovarian, and other cancers. It also develops VERU-111/VERU-112, a novel oral agent targeting colchicine binding site that is under preclinical study for the treatment of gout and familial mediterranean fever. Veru Inc. serves agencies, non-government organizations, ministries of health, and other governmental agencies through distributors and retailers primarily in the United States, Brazil, Spain, France, and the United Kingdom. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Veru Inc. was founded in 1896 and is headquartered in Miami, Florida.

About OMNOVA Solutions

OMNOVA Solutions Inc. provides emulsion polymers, specialty chemicals, and engineered surfaces for various commercial, industrial, and residential end uses in the United States, Europe, and Asia. The company operates in two segments, Specialty Solutions and Performance Materials. The Specialty Solutions segment designs, develops, produces, and markets specialty polymers which are used in various applications, such as architectural and industrial coatings; nonwovens used in hygiene products, filtration, and construction; drilling additives for oil and gas drilling, cementing, and fracking; elastomeric modification of plastic casings and hoses used in household, industrial products, and automobiles; tapes and adhesives; sports surfaces; textile finishes; commercial building refurbishment; new construction; residential cabinets; flooring; ceiling tiles; furnishings; manufactured housing; health care patient; common area furniture; and various industrial films applications. This segment primarily sells its products directly to manufacturers. The Performance Chemicals segment produces resins, binders, antioxidants, hollow plastic pigments, coated fabrics, and rubber reinforcing products which are used in tire cord, polymer stabilization, industrial rubber, carpet, paper, and various other applications. This segment distributes its products primarily through a direct sales force and agents to manufacturers of retail store fixtures, cabinets, furniture, seating, health care components, and other products. OMNOVA Solutions Inc. was founded in 1999 and is headquartered in Beachwood, Ohio.

Receive News & Ratings for Female Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Female Health and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

SmileyCoin Reaches Market Capitalization of $1.87 Million
SmileyCoin Reaches Market Capitalization of $1.87 Million
DeltaCredits Market Capitalization Reaches $0.00
DeltaCredits Market Capitalization Reaches $0.00
Reviewing Piedmont Office Realty Trust  & Sampo Group
Reviewing Piedmont Office Realty Trust & Sampo Group
Havven  Price Up 28% Over Last 7 Days
Havven Price Up 28% Over Last 7 Days
Head to Head Survey: Roper Technologies  & Mesa Laboratories
Head to Head Survey: Roper Technologies & Mesa Laboratories
Comparing PCM  & The Competition
Comparing PCM & The Competition


© 2006-2018 Ticker Report. Google+.